# The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

> **NCT05882903** · PHASE2 · RECRUITING · sponsor: **Oticara Australia PTY LTD** · enrollment: 24 (estimated)

## Conditions studied

- Chronic Rhinosinusitis (Diagnosis)

## Interventions

- **DRUG:** Betamethasone Dipropionate Nasal Cream 0.0644%
- **DEVICE:** Pre-filled syringe and applicator device

## Key facts

- **NCT ID:** NCT05882903
- **Lead sponsor:** Oticara Australia PTY LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-17
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05882903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05882903, "The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05882903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*